Clinical Trial Update: Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated single and multiple dose escalation and a two-sequence crossover design for ONO-9054 in ocular hypertension or mild open-angle glau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ONO-9054 (ONO-9054)

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Ocular Hypertension (OHT), Mild Open Angle-glaucoma (OAG) | Phase 1 | Status: COMPLETED